Table 9. Baseline clinicopathological findings of patients with the higher COP-NLR (1, 2) according to operative procedure.
| Characteristics | Patients(n=70) | operative procedure | ||
|---|---|---|---|---|
| radical (n=65) | partial (n=5) | p value | ||
| Age (mean±SD) | 64.6±10.9 | 64.2±10.6 | 61.0±15.1 | 0.450 |
| Sex (male/female) | 45/25 | 42/23 | 3/2 | 0.837 |
| BMI (≤22/>22) | 31/39 | 28/37 | 3/2 | 0.464 |
| ECOG-PS (0/≥1) | 56/14 | 52/13 | 4/1 | 1.000 |
| T classification (I/II/III/IV) | 48/7/13/2 | 43/7/13/2 | 5/0/0/0 | 0.267 |
| Histology type (clear/papillary/chromophobe/others) | 64/3/1/2 | 59/3/1/2 | 5/0/0/0 | 0.818 |
| Tumor size (cm) (mean±SD) | 4.1±2.4 | 4.5±2.4 | 1.8±0.4 | <0.001* |
| Nuclear grade (1-2/3-4) | 53/17 | 48/17 | 5/0 | 0.088 |
| Tumor Necrosis (absent/present) | 56/14 | 51/14 | 5/0 | 0.127 |
| C-reactive protein (mg/l) (mean±SD) | 22.1±47.0 | 23.5±48.5 | 4.6±7.3 | 0.391 |
| 5 year overall survival rate (%) | 66.6 | 66.1 | 80.0 | - |
COP-NLR: the combination of platelet count and neutrophil lymphocyte ratio, SD: standard deviation, BMI: body mass index, ECOG-PS: eastern cooperative oncology group-performance status, *p<0.05.